Epredia is a global leader in the anatomical pathology field, providing a comprehensive range of solutions for precision cancer diagnostics. From instruments to microscope slides and dyeing reagents, these solutions help to improve workflow efficiency from specimen collection to analysis, to enable safer, quicker, and more accurate diagnoses of cancer.

Epredia was established following the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business by PHC Holdings in 2019. Today, it is a global precision cancer diagnostics company that is committed to achieving its mission to improve lives by enhancing cancer diagnostics for patients around the world. Every second of every hour of every day, 44 of our products are employed in the battle against cancer.

Epredia has a high-quality and varied product line-up that meets the needs of pathologists and researchers in medical institutions and research facilities, helping them to improve lives for patients. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, the company’s solutions have and will continue to transform the anatomical pathology market.